The nasal allergy treatment market is projected to grow from USD 8.0 billion in 2025 to USD 15.3 billion by 2035, at a CAGR of 6.7%. Allergic Rhinitis will dominate with a 41.7% market share, while tablets/capsules will lead the form segment with a 47.3% share.